Anika Therapeutics (ANIK)

$25.47 0.27 (1.07%)

16:00 EDT ANIK Stock Quote Delayed 30 Minutes

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings Aug 8, 2024

ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024

3 Sorry Penny Stocks to Sell in August Before It’s Too Late

7 Stocks to Buy Before the Market Starts to Soar in 2023

Volume:

Previous Close -

Market Cap 377.68M

PE Ratio -5.02

EPS -5.07

Volume (Avg. Vol.) 43,594

Day's Range $25.01 - $26.00

52-Week Range $16.81 - $29.12

Dividend & Yield N/A (N/A)

ANIK Stock Predictions, Articles, and Anika Therapeutics News

3 Naked Puts to Bank $1,000-Plus in July Cash

By Lawrence Meyers, InvestorPlace Contributor Jul 6, 2017

Unless you're adverse to money, selling naked puts is a great way to generate some free cash to spend for the rest of your summer vacations.

7 Health Care Equipment & Supplies Stocks to Buy Now

By Portfolio Grader Dec 26, 2016

7 Health Care Equipment & Supplies stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!

By Jeff Reeves Oct 11, 2016

Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.

16 Health Care Equipment & Supplies Stocks to Buy Now

By Portfolio Grader Oct 3, 2016

The grades of 16 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

13 Health Care Equipment & Supplies Stocks to Buy Now

By Portfolio Grader Sep 26, 2016

The grades of 13 Health Care Equipment & Supplies stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

10 Biotech Stocks With Symptoms of Strong Growth

By James Brumley, InvestorPlace Feature Writer May 31, 2016

Most sectors are overextended and ripe for weakness, but biotech stocks are the exception. Put these names on your list of stocks to buy this summer.

Anika Therapeutics: A Hot Small Cap Flying Under the Radar

By Lawrence Meyers, InvestorPlace Contributor Dec 5, 2014

Anika Therapeutics is a small-cap biotech company with real products, real revenues and very real earnings driving its stock price higher.

3 Naked Puts With High Premiums, Little Risk

By Lawrence Meyers, InvestorPlace Contributor Sep 24, 2014

Naked puts on stocks that you wouldn't mind holding anyway is a great way to earn options income while reducing your risk.

4 Biotech Stocks to Buy

By James Brumley, InvestorPlace Feature Writer Aug 4, 2014

If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy

3 Healthcare Stocks to Buy Before Earnings

By Louis Navellier, Editor, Growth Investor Jul 18, 2014

Healthcare is a fast-growing segment of the market -- but which healthcare stocks should you buy? Let's take a look at 3 winners before earnings.

Anika Therapeutics (ANIK)

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024

ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024

3 Sorry Penny Stocks to Sell in August Before It’s Too Late

7 Stocks to Buy Before the Market Starts to Soar in 2023

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Anika Therapeutics (ANIK)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ANIK Stock Predictions, Articles, and Anika Therapeutics News

Subscriber Sign in